Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolin Fang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biomolecules|September 28, 2021
Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer ProgressionZihao Liu, Yu Shi, Qun Lin, et al.
Biochemical and Biophysical Research Communications|December 6, 2014
MicroRNA-196b promotes cell proliferation and suppress cell differentiation in vitroDonglin Cao, Liangshan Hu, Da Lei, et al.
Cancers|November 27, 2025
Correction: Lin et al. Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone. <i>Cancers</i> 2021, <i>13</i>, 5703Qun Lin, Xiaolin Fang, Gehao Liang, et al.
Cancers|November 27, 2021
Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in BoneQun Lin, Xiaolin Fang, Gehao Liang, et al.
Talanta|June 13, 2025
A simple and low-cost paper chip-based smartphone sensor for enumeration of T lymphocyte subsetsWei Xiao, Fengjuan Xu, Cong Lin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 26, 2022
Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3Zihao Liu, Yu Shi, Li Lv, et al.
The Oncologist|June 30, 2023
Association of FTH1-Expressing Circulating Tumor Cells With Efficacy of Neoadjuvant Chemotherapy for Patients With Breast Cancer: A Prospective Cohort StudyShijie Jia, Yaping Yang, Yingying Zhu, et al.
The Journal of Clinical Investigation|May 15, 2026
Targeting RANKL-independent osteoclastogenesis overcomes denosumab resistance in models of ER+ breast cancer bone metastasisQun Lin, Jinpeng Luo, Zhuxi Duan, et al.
Molecular Cancer|January 4, 2022
circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancerYun Ling, Gehao Liang, Qun Lin, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biomolecules|September 28, 2021
Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer ProgressionZihao Liu, Yu Shi, Qun Lin, et al.
Biochemical and Biophysical Research Communications|December 6, 2014
MicroRNA-196b promotes cell proliferation and suppress cell differentiation in vitroDonglin Cao, Liangshan Hu, Da Lei, et al.
Cancers|November 27, 2025
Correction: Lin et al. Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone. <i>Cancers</i> 2021, <i>13</i>, 5703Qun Lin, Xiaolin Fang, Gehao Liang, et al.
Cancers|November 27, 2021
Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in BoneQun Lin, Xiaolin Fang, Gehao Liang, et al.
Talanta|June 13, 2025
A simple and low-cost paper chip-based smartphone sensor for enumeration of T lymphocyte subsetsWei Xiao, Fengjuan Xu, Cong Lin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 26, 2022
Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3Zihao Liu, Yu Shi, Li Lv, et al.
The Oncologist|June 30, 2023
Association of FTH1-Expressing Circulating Tumor Cells With Efficacy of Neoadjuvant Chemotherapy for Patients With Breast Cancer: A Prospective Cohort StudyShijie Jia, Yaping Yang, Yingying Zhu, et al.
The Journal of Clinical Investigation|May 15, 2026
Targeting RANKL-independent osteoclastogenesis overcomes denosumab resistance in models of ER+ breast cancer bone metastasisQun Lin, Jinpeng Luo, Zhuxi Duan, et al.
Molecular Cancer|January 4, 2022
circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancerYun Ling, Gehao Liang, Qun Lin, et al.
Pageof 4